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The venom of the European black widow spider Latrodectus tredecimguttatus (Theridiidae) 
contains several high molecular mass (110–140 kDa) neurotoxins that induce neurotransmitter 
exocytosis. These include a vertebrate-specific α-latrotoxin (α-LTX-Lt1a) responsible for the 
clinical symptoms of latrodectism and numerous insect-specific latroinsectoxins (LITs). In contrast, 
little is known about the expression of these toxins in other Latrodectus species despite the fact 
that envenomation by these spiders induces a similar clinical syndrome. Here we report highly 
conserved α-LTX, α-LIT and δ-LIT sequence tags in L. mactans, L. hesperus and L. hasselti 
venoms using tandem mass spectrometry, following bioassay-guided separation of venoms by 
liquid chromatography. Despite this sequence similarity, we show that the anti-α-LTX monoclonal 
antibody 4C4.1, raised against α-LTX-Lt1a, fails to neutralize the neurotoxicity of all other 
Latrodectus venoms tested in an isolated chick biventer cervicis nerve-muscle bioassay. This 
suggests that there are important structural differences between α-LTXs in theridiid spider venoms. 
We therefore cloned and sequenced the α-LTX from the Australian red-back spider L. hasselti (α-
LTX-Lh1a). The deduced amino acid sequence of the mature α-LTX-Lh1a comprises 1180 
residues (~132 kDa) with ~93% sequence identity with α-LTX-Lt1a. α-LTX-Lh1a is composed of an 
N-terminal domain and a central region containing 22 ankyrin-like repeats. The presence of two 
furin cleavage sites, conserved with α-LTX-Lt1a, indicates that α-LTX-Lh1a is derived from the 
proteolytic cleavage of an N-terminal signal peptide and C-terminal propeptide region. However, 
we show that α-LTX-Lh1a has key substitutions in the 4C4.1 epitope that explains the lack of 
binding of the monoclonal antibody.  
 
Abbreviations: α-LTX, α-latrotoxin; BSA, bovine serum albumin; 4C4.1, murine monoclonal 
antibody raised against α-latrotoxin from L. tredecimguttatus; CBCNM, chick biventer cervicis 
nerve-muscle; CNS, central nervous system; ESI-Q-TOF, electrospray ionization quadrupole time-
of-flight; FPLC, fast performance liquid chromatography; gDNA, genomic DNA; HEPES, N-2-
hydroxyethylpiperazine-N-2-ethanesulfonic acid; α-LCT, α-latrocrustatoxin; LD50, median lethal 
dose; LIT, latroinsectotoxin; LMWP, low molecular weight protein (also known as latrodectin); MS-
MS, tandem mass spectrometry; RP-HPLC, reverse-phase high-performance liquid 





The most clinically significant group of spiders worldwide are the widow or comb-footed spiders, 
belonging to the genus Latrodectus (Araneae: Araneomorphae: Theridiidae). Widow spider 
envenomation manifests clinically as latrodectism, resulting in pain either at the bite site or 
radiating proximally to the whole of the bitten limb, local and regional diaphoresis, and less 
commonly piloerection and muscle fasciculation. Symptoms may become severe and generalized 
and include hypertension, tachycardia, nausea, vomiting, and abdomen, back or chest pain. 
Although death is uncommon, patients may be left with symptoms of envenomation for days or 
weeks if left untreated [1, 2].  
The toxin responsible for the clinical symptoms of latrodectism is the vertebrate-specific 
α-latrotoxin (α-LTX) which has been isolated from the venom of the European widow spider, 
L. tredecimguttatus [3]. α-LTX is a large ~130 kDa hydrophilic protein that elicits massive 
spontaneous neurotransmitter release from neuronal and neuroendocrine nerve terminals [4-6]. 
Under non-reducing conditions, α-LTX exists as a homodimer [7] with each monomer composed of 
four domains: a signal peptide (domain I), a conserved N-terminal domain with two hydrophobic 
segments that has no substantial homology to known proteins (domain II), a domain composed of 
20 ankyrin repeats (or 22 if two imperfect repeats are included; domain III), and a C-terminal 
propeptide domain (domain IV) [8]. α-LTX is synthesized as a larger preprotoxin of ~157 kDa 
where domains I and IV are believed to be removed by proteolytic cleavage during venom 
maturation by the endopeptidase furin, leaving a mature 130 kDa toxin composed of domains II 
and III [8-11]. Using electron cryo-microscopy, the 3D structure of the mature α-LTX monomer was 
found to contain three regions: the wing (majority of domain II), the body (one quarter of domain II 
and first 15–16 ankyrin repeats) and the head (ca. 4.5 C-terminal ankyrin repeats) [7]. 
L. tredecimguttatus venom also contains five insect-specific toxins known as latroinsectotoxins 
(LIT) α, β, γ, δ and ε [12], and one crustacean-specific protein, α-latrocrustatoxin (α-LCT) [13-15]. 
Of these, an additional three latrotoxins have been cloned and fully sequenced: α-LCT [16], α-LIT 
[9] and δ-LIT [10] with molecular masses of 110–140 kDa. In addition, two acidic low molecular 
weight proteins (LMWPs or latrodectins; ~7.9 kDa) have been found to co-purify with α-LTX [17-
19]. α-LTX-associated LMWPs are structurally related to crustacean hyperglycemic hormones and 
are non-toxic [17, 18, 20]. Nevertheless they appear to augment the neurotoxicity of latrotoxins [12, 
20], probably by increasing their affinity for the membrane target [21] and reducing vertebrate 
phyla-specificity such that α-LTX becomes active in insects [20]. 
Currently, α-LTX-induced neurotransmitter exocytosis is believed to involve an initial step of α-LTX 
binding to extracellular cell surface membrane proteins. Three structurally-unrelated cell adhesion 
receptor classes have been identified to mediate this increase in neurotransmitter release by 
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α-LTX: (i) neurexin 1α, a neuronal protein with a single transmembrane domain [22, 23], (ii) 
latrophilin 1 (CL1 or lectomedin) otherwise known as calcium-independent receptor of α-LTX 
(CIRL; [24, 25]; a member of the CL family of G-protein-coupled receptors [26, 27]), and more 
recently (iii) receptor-like protein tyrosine phosphatase σ [28]. It is believed that these receptors 
serve as sites to target α-LTX to the appropriate location on the cell surface, such as the active 
zone of nerve terminals at the neuromuscular junction [29]. Once bound, α-LTX oligomerization 
occurs allowing the formation of amphipathic cyclical tetramers, followed by membrane insertion 
and non-selective cation channel formation [7]. This pore formation results in an osmotic-mediated 
increase in vesicular exocytosis and non-vesicular leakage of neurotransmitters. In parallel, vesicle 
exocytosis ensues as a result of Ca2+ influx through the toxin-induced pore, and receptor-mediated 
vesicle exocytosis. Interestingly, the anti-α-LTX monoclonal antibody 4C4.1 blocks 
neurotransmitter release by preventing tetramerization of L. tredecimguttatus α-LTX and also 
inhibits the ionophore activity of α-LTX once inserted into cell membranes [30, 31]. The epitope of 
the monoclonal antibody 4C4.1 is located in a hinge region between the body and head of α-LTX, 
thus highlighting the importance of this region in pore formation and toxicity. 
While extensive investigations have been carried out on toxins from L. tredecimguttatus venom, 
remarkably little research has been undertaken on the composition of venoms from other 
Latrodectus species, including the clinically significant Australian red-back spider L. hasselti. 
Nevertheless, the venoms of all Latrodectus species are believed to contain similar α-LTX-like 
proteins since envenomation by any widow spider results in a similar clinical syndrome. Moreover, 
widow-spider antivenoms, produced using the venoms of specific Latrodectus species, reverse the 
effects of envenomation from other Latrodectus and Steatoda spiders (another member of the 
family Theridiidae) both in experimental animal models and in clinical settings [32-35]. The 
presence of a 130 kDa band in the venom of many theridiid spiders, detected by immunoblotting 
with red-back spider antivenom, suggests the presence of α-LTX-like or antigenically similar 
proteins in the venoms of all Latrodectus species as well as the related theridiid spider Steatoda 
grossa [32]. It has therefore been assumed, but not proven, that α-LTX is present in the venom of 
all widow spiders. The aim of the present study was therefore to determine whether the clinical 
symptoms of envenomation by other Latrodectus species and S. grossa can be explained by the 
presence of α-LTX molecules related to those found in L. tredecimguttatus venom. 
2. MATERIALS AND METHODS 
2.1 Sources of venoms, toxins and antibodies 
Purified α-LTX, derived from L. tredecimguttatus, was obtained from Alomone Laboratories 
(Jerusalem, Israel), reconstituted in 50% v/v glycerol and stored at –20°C. Female L. mactans 
(Southern black widow spider), L. hesperus (Western black widow spider) and L. lugubris (Ili River 
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Valley widow spider, Kazakhstan) venoms were obtained as lyophilized milked venom, extracted 
by electrostimulation of the venom apparatus, from Spiderpharm. Female L. tredecimguttatus 
venom was purchased as lyophilized venom gland extract from Latoxan (Rosans, France). Whilst 
originally described as a separate theridiid spider species, L. lugubris may simply represent a 
geographic variant of L. tredecimguttatus as Platnick [36] no longer recognizes this species as 
distinct from L. tredecimguttatus. All venoms were reconstituted in water and stored at –20°C. 
Female L. hasselti (Australian red-back spider) venom was purchased from Venom Supplies Pty. 
Ltd. (Tanunda SA, Australia), as lyophilized whole venom glands or obtained from venom glands 
freshly dissected from spiders donated to the Neurotoxin Research Group. Spiders were 
anaesthetized using CO2. Venom glands were removed through an incision on the dorsum of the 
cephalothorax and placed in 400–600 µl of water at 4°C. The glands were then crushed in a 
glass/glass Dounce vessel and the homogenate centrifuged for 30 min at 10,000 g at 4°C. The 
resulting supernatant was lyophilized and stored at –80°C until required. S. grossa (Brown 
cupboard spider) venom was extracted from venom sacs dissected from spiders raised in the 
Neurotoxin Research Group. Spiders were originally obtained by field collection from Gore Hill, 
Sydney, Australia and were formally identified as S. grossa by Dr Robert J. Raven of the 
Queensland Museum (South Brisbane QLD, Australia). Venom was extracted in an identical 
fashion to that of L. hasselti. 
A rabbit-derived polyclonal antibody to α-LTX raised against the venom of L. tredecimguttatus was 
purchased from Alomone Laboratories. A murine-derived monoclonal antibody to α-LTX from the 
venom of L. tredecimguttatus (4C4.1) was produced according to the methods of Pescatori and 
Grasso [30], and supplied as lyophilized hybridoma supernatant by Dr Alfonso Grasso. This was 
reconstituted at a concentration of 5 µg/ml. 
2.2 Isolated vertebrate bioassays 
Vertebrate toxicity of whole theridiid spider venoms, or venom fractions, were bioassayed using the 
isolated chick biventer cervicis nerve-muscle (CBCNM) preparation as described previously [37]. 
All animal experimentation was approved by the Animal Care & Ethics Committee of the University 
of Technology, Sydney (RNSH/UTS 0011-036A). In antibody neutralization studies, Latrodectus 
spp. and S. grossa venom samples were pre-treated with 1 ml of reconstituted monoclonal 
antibody 4C4.1 solution and allowed to equilibrate with venom for 5 min at 37°C prior to application 
to the nerve-muscle preparation.  
2.3 Gel electrophoresis and Western blotting 
Western blotting was performed following initial sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) as described previously [32]. Purified Latrodectus spp. venom 
fractions were transblotted for subsequent protein sequencing by Edman degradation. The PVDF 
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membrane was incubated with 0.025% Coomassie blue R250 in 40% methanol for 30 min 
immediately after transblotting and destained with 50% methanol. Bands of interest were excised 
and sent for Edman sequencing (Australian Proteomic Analysis Facility, Macquarie University, 
Sydney, Australia) on an Applied Biosystems/Perkin Elmer Procise 492 cLC protein sequencer. 
Secondly, transblotted Latrodectus spp. and S. grossa venom proteins were incubated with 
polyclonal rabbit-derived anti-α-LTX antibody (1:100 dilution) or murine-derived anti-α-LTX 
monoclonal antibody 4C4.1 [30] as primary antibodies using previously described methods [32]. 
The blot was then incubated with specific secondary antibodies for 1 h. For the polyclonal anti-α-
LTX antibody a 1:10,000 dilution of alkaline phosphate conjugated goat anti-rabbit IgG (Sigma-
Aldrich) was used. For the anti-α-LTX monoclonal antibody 4C4.1, a 1:2,000 dilution of alkaline 
phosphate conjugated goat anti-mouse IgG (Sigma-Aldrich) was employed.  
2.4 Toxin purification and peptide sequencing  
One milligram samples of Latrodectus spp. and S. grossa venoms were initially purified by size-
exclusion fast performance liquid chromatography (FPLC) using a Superdex® 200 HR 10/30 FPLC 
column (1 x 30 cm, Pharmacia-Biotech, Uppsala, Sweden) using a buffer of 20 mM Tris/NaCl, pH 
7.6 and a flow rate of 0.5 or 1 ml/min. β-Galactosidase (118 kDa) was used as an indicator of the 
retention time as its mass is similar to α-LTX. Protein fractions were monitored at 215 and 280 nm 
using a Pharmacia LKB variable wavelength monitor model 2141 (Pharmacia-Biotech). Venom 
fractions were collected manually and stored at 4°C. Further fractionation of the high molecular 
mass fractions was performed using anion-exchange FPLC within one day. 
Anion-exchange FPLC was performed using a Mono Q® HR 5/5 FPLC column (Pharmacia-
Biotech). Protein fractions were eluted using 20 mM Tris/NaCl, pH 7.6 as the mobile phase, 
employing a linear NaCl gradient from 20 to 400–600 mM over 30-35 min at a flow rate of 1 ml/min. 
Desalting of anion-exchange FPLC fractions was performed using either a HiTrap® Desalting 
Column (Pharmacia-Biotech) or using reverse-phase high pressure liquid chromatography (RP-
HPLC; see below). After desalting, fractions were lyophilized and stored at –80°C. 
Further separation, prior to Edman sequencing and MS-MS, was performed using an analytical 
C18 RP-HPLC column (25 cm x 4.6 mm, 5 µm pore size; Vydac, Hesperia, CA, USA). The column 
was equilibrated with 95% buffer A consisting of 0.1% v/v trifluoroacetic acid (TFA) in water and 
5% buffer B (0.085% v/v TFA in acetonitrile). Elution of venom components was achieved using a 
linear gradient of 5–50% buffer B over 30 min followed by a linear gradient of 50–70% buffer B 
over 35 min at flow rate of 1 ml/min. Purified toxins were collected, lyophilized, and stored at –80˚C 
until required. Toxin quantification was performed using a bicinchoninic acid protein assay kit 
(Pierce, Rockford, IL, USA) using bovine serum albumin as a standard. Absorbances were read at 
560 nm on a Titertek Multiscan microplate reader (Eflab, Finland).  
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2.5 Acute Insect Toxicity Testing 
For analysis of insecticidal activity, anion-exchange FPLC fractions were dissolved in insect saline 
with 0.1% BSA and injected into house crickets (Acheta domesticus) as previously described [38]. 
Groups of 3–5 crickets received intrathoracic injections at a dose of 1 µg/g. A control group of 
three crickets were also injected with the same volume of 0.1% BSA in insect saline. Insects were 
monitored for 96 h following injection for signs of toxicity, and the percentage knockdown and 
lethality was determined. Knockdown was defined as the inability to maintain an upright posture, 
with intermittent or continuous twitches of appendages. 
2.6 α-LTX fragment sequencing by tandem mass spectrometry 
Purified protein samples were analyzed using electrospray ionization time-of-flight tandem mass 
spectrometry (ESI-Q-TOF MS). Briefly, samples were purified after fractionation by RP-HPLC 
using SDS-PAGE gel electrophoresis on 15% Tris-glycine gels as described above. Gels were 
stained with 0.025% Coomassie Blue R-250 in 40% methanol for 20 to 30 min and destained with 
50% methanol. Protein bands of interest were excised from the gel, dried, and exposed to a 16 h 
tryptic digestion at 37°C prior to peptide analysis. The resulting peptides were purified using a 
ZipTip® (Millipore, Bedford, MA, USA) to concentrate and desalt the samples. The samples were 
then analyzed by tandem mass spectrometry (MS-MS) using a Micromass Q-TOF MS equipped 
with a nanospray source (Micromass, Manchester, England). Samples were dissolved in 5 µl 50% 
acetonitrile and 0.5% formic acid. Data were manually acquired in the positive mode using 
borosilicate capillaries with a source temperature of 80°C. A potential of 850 V was applied to the 
nanoflow tip. Data were acquired over the m/z range 400–1,800 to select peptides for MS-MS 
analysis. After peptides were selected, the MS was switched to MS-MS mode and the data 
collected over the m/z range 50–2,000 with variable collision energy settings. Peptides were 
subsequently compared with the known amino acid sequences of α-LTX, α-latroinsectotoxin, and 
δ-latroinsectotoxin using NCBI-Blast protein-protein comparison which uses the protein sequences 
derived from the venom of L. tredecimguttatus for sequence homology [8, 10, 39]. Raw data were 
processed using the MAXENT algorithm included in the MASSLYNX program. 
2.7 Genomic DNA extraction from L. hasselti 
Two L. hasselti spiders were immobilized by freezing at –20°C for 5 min and their cephalothoraces 
dissected. Cell lysis was performed by firstly crushing the cephalothoraces in 500 µl of 4 M 
guanidium isothiocyanate (GITC) (Sigma-Aldrich) in 100 mM Tris (pH 7.0) with 0.1% β-
mercaptoethanol. Fifty microlitres of 3 M sodium acetate (pH 5) and 500 µl of phenol (saturated 
solution, pH 6.6) were then added sequentially to extract the proteins. Subsequent to this, 100 µl of 
chloroform/isoamyl alcohol (49:1) was added to extract the cellular proteins. The solution was 
centrifuged at 10,000 g for 10 min to separate the aqueous and organic layers. The upper layer 
and genomic DNA (gDNA) interface were carefully pipetted from the protein layer and placed in 
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separate tube where DNA precipitation was performed. To the suspension was added two volumes 
of 100% ethanol at room temperature. The precipitate was subsequently centrifuged at 10,000 g 
for 15 min resulting in the formation of a DNA pellet. The supernatant was decanted from the DNA 
pellet and the pellet resuspended in 100 µl dH2O. 
gDNA used for the amplification of the segment which comprises bases 3320-3830 in the 
nucleotide sequence, was obtained from dissected legs that were ground with a chilled, sterile 
mortar and pestle in liquid nitrogen. After pulverization, the tissue (~100 mg) was added to 400 µl 
of low salt buffer as previously described [40]. Before amplification by the Polymerase Chain 
Reaction (PCR), quality and quantity of all extracted DNA was assessed by measuring the 
OD260/280 and by running a 1.1% agarose gel, stained with SyberSafe®.  
2.8 PCR and Sequencing 
Non-degenerate paired forward and reverse DNA primers were designed from the previously 
determined DNA sequence of L. tredecimguttatus α-LTX [8] and peptide sequences derived from 
MS-MS sequencing. Primer pairs were selected at approximately 400–600 bp distances and 
Primerfinder (http://eatworms.swmed.edu/~tim/primerfinder/) was utilized to reduce the likelihood 
of primer dimers or hairpins. Primers were supplied by Sigma GenoSys, Australia. 
Red-Taq DNA Polymerase (Sigma) was used to amplify all segments of the α-LTX from L. hasselti 
by PCR, except for the segment at position 3320–3830 bp which was amplified using Platinum® 
Taq (Invitrogen). Each 50 µl reaction contained 250–300 ng of gDNA template, 1X Sigma PCR 
buffer (or 1X PCR reaction buffer and 1 mM MgCl2), 0.2 µM dNTPs, 0.6 µM of each forward and 
reverse primer, 1 U Taq Red-Taq polymerase (or 1U Platinum Taq polymerase). Cycling conditions 
were: 1 min at 94°C followed by 35 cycles of 94°C for 30 s, 50°C for 30 s, 72°C for 1 min and a 
final cycle of 72°C for 10 min. 
The PCR products were purified using the QIAGEN QIAquick PCR purification kit and sent directly 
for sequencing whereas clean PCR products from the segment 3320-3830bp were cloned into the 
pCR II® vector using the TA dual Cloning Kit (Invitrogen). The resulting clones were grown 
overnight in LB media with ampicillin. Plasmids were extracted using the QIAprep Spin Miniprep 
kit. Sequencing was performed at the Sydney University Prince Alfred Macromolecular Analysis 
Centre (SUPAMAC) where samples were prepared and mixed with 70 to 100 pmol of respective 
forward or reverse primers. In later experiments sequencing was performed at the Australian 
Genome Research Facility (AGRF - Brisbane node) in a reaction containing 3 µl of Plasmid DNA 
with M13 primers.  Sequences were aligned and analyzed using MACVECTOR (v11.0.4) or GENEIOUS 
PRO software (v4.8.3) 
Given the similar, but non-identical, sequences of the α-LTX peptides determined in this work 
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when compared to α-LTXs from L. tredecimguttatus, it is proposed that a new nomenclature 
system be employed to describe the α-LTX homologs from other Latrodectus venoms. 
Accordingly, we used a nomenclature based on that recently described for venom peptides [41] 
and which has already been adopted by ArachnoServer [42, 43] and UniProtKB [44]. Hence, 
α-latrotoxin from L. tredecimguttatus is renamed α-latrotoxin-Lt1a (α-LTX-Lt1a) and α-latrotoxins 
from the venom of L. hasselti, L. hesperus and L. mactans are named α-LTX-Lh1a, α-LTX-Lhe1a 
and α-LTX-Lm1a, respectively, in order to clearly distinguish them from α-LTX-Lt1a. 
3. RESULTS 
3.1. In vitro monoclonal antibody neutralization studies 
The venoms from L. tredecimguttatus, L. lugubris, L. hesperus and L. hasselti (Fig. 1, top panels) 
all produced a characteristic rapid muscle contracture and loss of twitch tension when added to the 
isolated and indirectly-stimulated chick biventer cervicis nerve-muscle (CBCNM) preparation. This 
is consistent with the known ability of α-LTX to increase neurotransmitter release in this 
preparation [32, 45]. The murine-derived monoclonal antibody 4C4.1, raised against α-LTX-Lt1a 
from L. tredecimguttatus, was then assayed for its ability to inhibit the in vitro effects of these 
Latrodectus venoms. The responses of L. tredecimguttatus venom on twitch tension and 
contracture were inhibited by 4C4.1 in a dose-dependent fashion. Following a 5 min incubation 
with 1 ml of 4C4.1 (5 µg/ml) at 37°C, L. tredecimguttatus venom failed to alter twitch tension 
(Fig. 1Ab). Incubation with reduced amounts of 4C4.1 (<2.5 µg/ml) resulted in the production of a 
moderate contracture and slow, but eventual, loss of twitch tension (data not shown). In contrast, 
incubation with 1 mL of 4C4.1 failed to prevent the typical, rapid contracture associated with 
diminishing twitch tension associated with L. lugubris, L. hesperus, and L. hasselti venoms 
(Fig. 1Bb, Cb and Db). These observations suggest that either the concentration of antibody was 
insufficient to completely block the neurotoxic effects of these latter venoms or more likely that the 
epitope that binds 4C4.1 may not be present in the α-LTX-like molecules found in other 
Latrodectus venoms.  
3.2 Venom electrophoresis and Western blotting 
SDS-PAGE revealed comparable high molecular mass proteins for all Latrodectus spp. venoms 
with a protein band around 130 kDa, consistent with the presence of α-LTX (Fig. 2A). Subsequent 
Western blotting with polyclonal anti-α-LTX-Lt1a antibody revealed that this 130-kDa band present 
in all venoms has antigenic similarity to α-LTX-Lt1a from L. tredecimguttatus (Fig. 2B). In support, 
Western blotting with the monoclonal antibody 4C4.1 showed binding with α-LTX-Lt1a derived 
from L. tredecimguttatus venom as well as the 130-kDa band found in L. tredecimguttatus 
(Fig. 2C). Interestingly, however, no binding was observed with any protein bands found in 
L. hasselti, L. mactans, L. hesperus, or with the α-LTX-like protein previously described in 
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S. grossa venom [46], (Fig. 2C) or with L. lugubris (data not shown). These results are consistent 
with the inability of 4C4.1 to neutralize the neurotoxicity of L. hasselti, L. hesperus, and L. lugubris 
venoms. This indicates that the epitope responsible for binding 4C4.1 is either not present, or is 
modified, in the α-LTX molecules found in other Latrodectus venoms and suggests that the protein 
structure of these toxins may vary from the known structure of α-LTX-Lt1a [47].  
3.3 Size-exclusion FPLC 
Bioassay-guided fractionation of Latrodectus and S. grossa venoms was undertaken to provide 
proteins for N-terminal sequencing. Initial separation of venoms was undertaken using size 
exclusion FPLC employing isocratic elution with 20 mM Tris/NaCl (pH 7.6). These conditions are 
similar to that used previously for the separation of α-LTX-Lt1a from L. tredecimguttatus venom 
[48]. The chromatograms resulting from fractionation of the venoms of L. tredecimguttatus, 
L. lugubris, L. hasselti, and S. grossa all contained a high molecular mass fraction (~200 kDa) 
eluting at 8–12 min (Fig. 3A-D), a fraction containing intermediate masses (120–130 kDa) eluting 
at 12–18 min, and a number of lower molecular mass proteins eluting at longer retention times  
(Fig. 3H). In contrast, the venoms from L. mactans and L. hesperus were almost completely devoid 
of the high molecular mass fraction (Fig. 3E-F) and had reduced expression of lower molecular 
mass proteins (Fig. 3H); these venoms were instead dominated by the intermediate-mass fraction 
(shaded black in each of the chromatograms in Fig. 3). The early-eluting high-mass fraction may 
represent contaminant proteins extracted from the venom gland itself, although this fraction is 
present in the venom from L. lugubris milked by electrostimulation. The intermediate-mass fraction 
had a similar retention time to β-galactosidase (118 kDa; Fig. 3G), suggesting that it likely contains 
α-LTX-like molecules. Consistent with this hypothesis, these fractions exhibited an increased 
muscle contracture and decreased twitch tension similar to crude venom extracts when bioassayed 
using the CBCNM preparation (data not shown). Interestingly, the 120–130 kDa size-exclusion 
fraction from S. grossa venom exhibited much less activity in the nerve-muscle bioassay with 
minimal increases in muscle contracture seen in the absence of any changes in twitch tension. 
This is consistent with the observations made earlier in comparisons of the bioactivity of crude 
venom from this species with that of Latrodectus spp. venoms [46]. 
Initial attempts at using C18 RP-HPLC fractionation employing 0.1% TFA in acetonitrile resulted in 
loss of activity of resultant venom fractions bioassayed using the CBCNM preparation. This was 
most likely due to the acidic/denaturing environment resulting in neutralization of toxin activity. 
Therefore all 120–130 kDa venom fractions were subsequently purified by anion exchange FPLC. 
3.4 Anion Exchange FPLC 
The intermediate-mass FPLC fractions exhibiting neurotoxic actions in the CBCNM bioassay were 
further separated by anion-exchange FPLC using a NaCl gradient. All Latrodectus spp. and 
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S. grossa venoms exhibited a large number of fractions that sequentially eluted with increasing 
NaCl concentration (Fig. 4A-F). Latrodectus venoms all contained a vertebrate-toxic fraction as 
determined by the CBCNM bioassay that resulted in a typical increase in resting muscle tension 
and loss of twitch tension (Fig. 4G-J) comparable to that observed with crude venom extract 
(Fig. 1Aa-Da). This was invariably found in the final peak eluting at a NaCl concentration of 360–
370 mM NaCl for L. tredecimguttatus (ƒ6) and L. lugubris (ƒ6), consistent with that previously seen 
for L. tredecimguttatus [11], and 440–460 mM for L. mactans (ƒ6), L. hesperus (ƒ6) and L. hasselti 
(ƒ7) (black peaks in Fig. 4A-E). SDS-PAGE of these anion-exchange fractions revealed that they 
contained at least one high-molecular mass protein band (120–130 kDa) with some also containing 
70-kDa contaminants (Fig. 5A-C). An attenuated response in the nerve-muscle preparation was 
also seen with the fraction immediately preceding these final fractions suggesting that there was 
some degree of cross-contamination of these venom fractions with the α-LTX-like protein found in 
the final fraction of each venom (data not shown). Furthermore, acute insect toxicity was observed 
in the L. hasselti (ƒ6), L. mactans (ƒ5), L. hesperus (ƒ5), and L. lugubris (ƒ5) anion-exchange 
fractions (white peaks in Fig. 4B-E) preceding the vertebrate-toxic fraction (black peaks in Fig. 4A-
E). In the insect bioassays, 30–100% knockdown was observed at 24 h postinjection, with 100% 
lethality at 96 h. The insect toxicity of these fractions suggests that the high-molecular weight 
bands seen on SDS-PAGE may contain latroinsectotoxin homologs.  
Attempts to isolate the vertebrate-active fraction of S. grossa venom using a similar method to that 
employed for the Latrodectus venoms were unsuccessful. Although the high molecular weight size 
exclusion fractions of the venom showed limited activity, the various anion-exchange fractions 
purified from the size-exclusion fractions failed to elicit a response in the CBCNM preparation. This 
suggests that the S. grossa anion-exchange venom fractions may have become inactivated during 
the fractionation process. Hence, further attempts at isolation and characterization of S. grossa 
toxins was not attempted.  
3.5 N-terminal sequencing of α-LTX-associated low molecular weight proteins 
N-terminal sequencing via Edman degradation was attempted using the vertebrate-active final 
peak of all the Latrodectus spp. venoms fractionated by anion-exchange FPLC. Initial attempts to 
sequence α-LTX from the vertebrate-active anion-exchange FPLC peak of L. tredecimguttatus (ƒ6) 
venom proved unsuccessful, with only a partial sequence of a co-eluting low-molecular weight 
protein (LMWP, also named latrodectin) associated with α-LTX [17-19, 21, 47] being identified (see 
Supplementary Fig. S1). Similarly, a partial N-terminal sequence of LMWP was identified from the 
corresponding vertebrate-active fraction (ƒ6) of L. lugubris venom (Supplementary Fig. S1). This 
showed 100% identity with the reported sequence of LMWP from L. tredecimguttatus, providing 
further support for the contention that L. lugubris is not a separate species from L. tredecimguttatus 
[36]. When sequencing was attempted using toxin resolved on SDS-PAGE and then transblotted to 
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PVDF membrane, LMWP was not detected. This suggests that SDS-PAGE followed by 
transblotting results in separation of the high (α-LTX) and low molecular mass (LMWP) proteins. 
We were unable to determine any similar sequences for LMWP from any other Latrodectus 
venoms either when on blot or direct sequencing of toxin were attempted. 
Attempts at N-terminal sequencing of α-LTX from the remaining vertebrate-active fractions of 
L. hasselti, L. mactans, or L. hesperus venom also failed when attempted in-solution or when 
transblotted onto PVDF membrane, suggesting that these toxins may be N-terminally blocked [39]. 
Given that the N-terminal residue of α-LTX-Lt1a is glutamate, N-terminal block may result from the 
conversion to pyroglutamate [49], which is resistant to N-terminal sequencing by Edman 
degradation [50]. As a result, the vertebrate-active peaks of L. hasselti, L. mactans, L. lugubris and 
L. hesperus venoms were subjected to SDS-PAGE and on-blot pyroglutamate aminopeptidase 
digestion in an attempt to cleave any N-terminal pyroglutamate. This method was unsuccessful 
suggesting that either the toxin may not have been present in sufficient quantities to be detected by 
this sequencing method, or that alternative post-translational modifications that interfere with 
Edman sequencing may be present [50]. 
3.6 MS-MS protein sequencing of latrotoxins 
To a derive a partial amino acid sequence of α-LTX homologs from Latrodectus venoms, MS-MS 
protein sequencing of tryptic-digest fragments of the vertebrate-active fractions was carried out. 
Initially, MS-MS sequencing was used to analyze tryptic-digest peptides from L. hasselti and 
L. hesperus vertebrate-active anion-exchange fractions ƒ7 and ƒ6, respectively. Interestingly, the 
peptides sequenced were highly homologous with α-LIT and δ-LIT [9, 10] and not α-LTX 
(Supplementary Fig. S2). Results are summarized in Table 1. This most likely arose as a result of 
significant cross-contamination with the immediately preceding latroinsectotoxin anion-exchange 
FPLC fractions (ƒ6 and ƒ5, respectively). However, it would not be possible to further separate 
these contaminants by size-exclusion FPLC or gel electrophoresis due to the similarity in the 
molecular masses of the toxins. Hence, further purification of α-LTX from the vertebrate-active 
anion-exchange FPLC fractions from L. hasselti (ƒ7), L. hesperus (ƒ6), and L. mactans (ƒ6) 
venoms was achieved using C18 RP-HPLC (Fig. 5D-F). Reverse-phase HPLC was not used 
earlier in the purification process as we had previously found that the mobile phase inactivated 
crude venom and venom fractions making it impossible to use the CBCNM bioassay to determine 
which fraction was vertebrate-active.  
C18 RP-HPLC fractionation of the vertebrate-active anion-exchange fraction from L. mactans and 
L. hesperus revealed nine and seven sub-fractions, respectively (Fig. 5D-E). For L. hesperus, three 
fractions contained proteins with a molecular mass of 120 kDa when separated on SDS-PAGE. 
Two of these were excised and subjected to a 16 h tryptic digestion. MS-MS analysis of two of 
14 
these peptide fragments revealed sequences homologous to α-LTX in ƒ6.6, and δ-latroinsectotoxin 
in ƒ6.4 (not analyzed further in view of previous amino acid sequence analysis). Although only two 
peptide sequences (22 amino acids in total) were determined, they exhibited 100% identity with 
α-LTX-Lt1a (Fig. 6, Table 1). 
For L. mactans, C18 RP-HPLC fractionation and subsequent SDS-PAGE analysis revealed two 
fractions (ƒ6.8 and ƒ6.9) containing a molecular mass of 120–130 kDa. Following tryptic digestion, 
both fractions contained peptide fragments with high homology with α-LTX-Lt1a. Fraction 6.8 
revealed 13 peptides containing 150 amino acids with 94.6% identity and 98% similarity with α-
LTX-Lt1a. Fraction 6.9 returned 10 peptides containing a total of 119 amino acids with 91.6% 
identity and 95.7% similarity with α-LTX-Lt1a (Fig. 6, Table 1). A number of peptides sequenced 
from these two fractions were identical. It is interesting that two α-LTX homologs were purified from 
L. mactans anion exchange vertebrate-active fraction by RP-HPLC. This suggests that there might 
be two distinct α-LTX isoforms in L. mactans venom with similar but not identical primary structure. 
Finally, L. hasselti ƒ7 yielded nine RP-HPLC fractions (Fig. 5F). Two fractions (ƒ7.7 and ƒ7.9) 
yielded 120–130 kDa bands when separated on SDS-PAGE. These were excised, subjected to 
tryptic digestion, and analyzed using MS-MS. No peptides could be identified in ƒ7.7. However, 
ƒ7.9 yielded four peptide sequences (total of 54 amino acids) that yielded a 100% sequence match 
with α-LTX-Lt1a [8] (Fig. 6, Table 1). 
3.7 Determination of the DNA sequence of Latrodectus hasselti α-LTX gene 
It was difficult to reconcile the 100% identity of the L. hasselti ƒ7.9 peptide fragments and α-LTX-
Lt1a with the observed lack of neutralization using the anti-α-LTX-Lt1a monoclonal antibody 4C4.1. 
We therefore decided to construct a L. hasselti genomic DNA library in order to be able to 
determine the complete sequence of the gene encoding the α-LTX-like protein. The choice of 
Latrodectus species was based on the ready availability of L. hasselti and the fact that it is a 
medically significant spider, associated with significant morbidity; this spider is estimated to be 
responsible for at least 5,000 envenomations per year in Australia [2]. 
Determination of the DNA sequence of α-LTX-Lh1a from the genomic DNA of this spider was 
performed in a stepwise fashion along the α-latrotoxin gene. This process resulted in the definitive 
determination of 3845 bases, covering the complete mature toxin sequence, including a three base 
insertion (bases +10–12, Fig. 7). Comparison with α-LTX-Lt1a revealed that the DNA sequence 
also covered 35% of the signal peptide and 81% of the C-terminal propeptide region of α-LTX-Lt1a 
[11]. There was 95.1% sequence identity between the DNA sequence encoding α-LTX-Lh1a with 
that encoding the mature α-LTX-Lt1a toxin (Fig. 7).  
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Translation of the genomic DNA sequence for α-LTX-Lt1a yielded a mature toxin comprising 1180 
amino acid residues with a predicted molecular mass of 132,514 Da and a pI of 5.72. 1097 (93%) 
of these residues are identical to those in the mature α-LTX-Lt1a toxin, which increases to 93.2% if 
three residues identical to a variant of α-LTX-Lt1a (AAC78471 in EMBL-Bank CDS) are included 
(V41, V143 and D1097). Of the 83 amino acid substitutions, 34 are conservative and 49 non-
conservative, resulting in an overall 93.8% similarity with α-LTX-Lt1a (Fig. 8). Importantly the 
deduced polypeptide contained all four partial amino acid sequences previously sequenced by 
tandem MS of ƒ7.9. Furthermore, the mature α-LTX-Lh1a also contains two hydrophobic segments 
in its N-terminal region, HS1 (residues 35–60) and HS2 (219–238) homologous to similar 
segments found in α-LTX-Lt1a (Fig. 8) and δ-LIT [10]. 
Analysis of the deduced amino acid sequence revealed the presence of 22 imperfect repeats (R1–
R22) at positions 439–1180 (Fig. 8). These comprise the ankyrin-like repeat motif previously 
described in α-LTX-Lt1a [8] and other latrotoxins [9, 10, 16] and divide the mature toxin into two 
domains: the N-terminal domain II (50,026 Da, 38%) and the ankyrin-rich domain III (82,506 Da, 
62%). Ankryin repeats are a sequence motif found in proteins with various functions including 
transcription initiation, cell cycle regulation, cytoskeletal integrity, ion transport, and cell-cell 
signaling [51]. These repeats have a consensus sequence as shown in Supplementary Fig. S2A 
[52, 53]. The 33-residue ankyrin repeats in α-LTX-Lh1a have a highly conserved length, except for 
R1, R16 and R17 (32 residues); similarity to the consensus sequence ranges from 9% (R16) to 
61% (R3 and R13). Analogous to α-LTX-Lt1a, repeats R1, R16 and R17 are atypical, imperfect 
repeats (Supplementary Fig. S2B). Finally, the putative binding site for 4C4.1 was derived from the 
DNA sequence for α-LTX-Lh1a (nucleotide bases 3156–3177). Importantly, α-LTX-Lh1a contains 
non-conservative F1009D and S1011N substitutions in the binding epitope when compared to α-
LTX-Lt1a.  
4. DISCUSSION  
Comparative Western blot analysis of Latrodectus spp. and S. grossa venoms using a polyvalent 
anti-α-LTX-Lt1a antibody revealed that all venoms contained proteins that are antigenically similar 
to those found in L. tredecimguttatus, in particular a 130 kDa band consistent with α-LTX. The 
pattern of expression is similar to that seen in Western blots employing polyvalent red-back spider 
antivenom, an equine-derived antibody composed of purified IgG-F(ab’)2 fragments produced from 
the venom of L. hasselti [32, 46]. These findings suggested the presence of an α-LTX-Lt1a-like 
protein in all Latrodectus spp. and S. grossa venoms. The subsequent identification of α-LTX and 
LIT sequences from Latrodectus venoms, other than L. tredecimguttatus, provides the first 
confirmation that α-LTXs are widely expressed in theridiid spiders. 
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Using non-degenerate primers based on the DNA sequence of α-LTX-Lt1a and MS-MS peptide 
sequences from L. hasselti RP-HPLC fractions, we were also able to determine the complete 
sequence of the novel α-LTX-Lh1a from the venom of the red-back spider L. hasselti. The primary 
structure of α-LTX-Lh1a has the same domain structure as α-LTX-Lt1a. α-LTX-Lh1a contains two 
furin-like endopeptidase cleavage sites coded for by a cluster of 4 basic residues: ‘RMRR’ at the N-
terminus (–4 to –1) and ‘KFRR’ at the C-terminus (1177–1180) followed by an acidic amino acid 
(glutamate). These conform to the (K/R)Φ1–3(K/R)0–1R, consensus sequence for proteolytic 
cleavage of α-LTX-Lt1a and LITs where K and R are lysine and arginine, respectively, and Φ is 
any hydrophobic/aromatic residue [54]. These furin sites are believed to be important for removal 
of the signal peptide and C-terminal propeptide in α-LTX-Lt1a [11]. Therefore α-LTX-Lh1a appears 
to be produced as a preprotoxin in a similar fashion to α-LTX-Lt1a. Unfortunately most of the 
nucleotide sequence upstream of the N-terminus of the mature protein could not be determined 
and therefore we cannot draw any conclusions about the size of the signal peptide and its 
homology to that of α-LTX-Lt1a. We sequenced 160 bases in the domain IV propeptide region but 
unfortunately we were unable to sequence to the stop codon 201 residues downstream of the furin 
cleavage site in α-LTX-Lt1a. However, within domain II and III, the cysteine residues important for 
structural stability and activity of latrotoxins [20, 55] as well as the two hydrophobic segments in 
domain II, were all conserved. In particular, the second hydrophobic segment (HS2) is highly 
conserved between α-LTX-Lh1a and all latro(insect/crusta)toxins (see [10]) and may, therefore, be 
involved in an important aspect of function in all latrotoxins. 
Despite the fact that all the venoms tested appeared to be antigenically similar when probed with 
polyclonal anti-α-LTX antibodies, the anti-α-LTX-Lt1a monoclonal antibody 4C4.1 failed to 
recognize venom from L. hasselti, L. hesperus, L mactans, and S. grossa. This was noted in both 
Western blots and in the inability of 4C4.1 to prevent the rapid muscle contracture and loss of 
twitch tension produced by these latter venoms in the CBCNM preparation. Thus, even though all 
Latrodectus and S. grossa venoms appear to contain α-LTX-like proteins, the epitope required for 
binding of the 4C4.1 antibody appears to be present only in the toxin from L. tredecimguttatus, or is 
at least significantly modified in the α-LTX-like toxins from other Latrodectus/Steatoda venoms. 
The putative binding site for 4C4.1 was determined directly by tandem MS from L. mactans ƒ7.9 
(α-LTX-Lm1a) and derived from the DNA sequence for α-LTX-Lh1a. Both α-LTX-Lm1a and α-LTX-
Lh1a contain a non-conservative F1028D substitution when compared to α-LTX-Lt1a. In addition, 
α-LTX-Lh1a also contains a non-conservative S1030N substitution. These substitutions explain the 
lack of binding of 4C4.1 to L. hasselti and L. mactans protein bands in Western blots, and also the 
lack of neutralizing activity of the antibody in the chick nerve-muscle preparation. L. hesperus α-
LTX-Lhe1a is also likely to contain similar substitutions that underlie the ineffectiveness of 4C4.1 in 
Western blots and neutralization assays.  
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The actions of α-LTX-Lh1a to cause rapid spontaneous neurotransmitter release, leading to an 
inhibition of neurotransmission at the chick neuromuscular junction, are indistinguishable from that 
of α-LTX-Lt1a (Fig. 4G-I). This results from the known action of LTXs to cause massive vesicle 
exocytosis [4-6]. This action is consistent with the clinical reports of latrodectism and animal 
studies using L. hasselti venom, including reports of muscle fasciculation, tremor, muscle paralysis, 
tachycardia, priapism, hypertension, salivation and diaphoresis resulting from excessive 
neurotransmitter release from motor and autonomic nerve endings [2, 32]. Since α-LTX-Lt1a 
shares a very high degree of sequence homology with α-LTX-Lh1a, and probably α-LTX-Lm1a and 
α-LTX-Lhe1a, this indicates that the subtle differences in structure between these α-LTX homologs 
do not significantly alter the intense neurotransmitter release seen in vitro with all Latrodectus 
venoms ([32] and Fig. 4G-I). These findings therefore provide strong support for the widely held 
assumption that the clinical symptoms of latrodectism are due to the presence of α-LTX homologs 
in all theridiid venoms.  
The in vitro, in vivo and clinical observations of the effectiveness of red-back spider antivenom in 
the treatment of latrodectism from a wide range of Latrodectus species [32-35] suggests that it may 
therefore be possible to use a single antivenom worldwide for the treatment of widow-spider 
envenomation. This is likely to impact less on regions that already have their own antivenom to 
treat envenomation by local Latrodectus species [56], but could potentially benefit many regions of 
the world where specific antivenoms to local widow spiders are not available. Given the success of 
red-back spider antivenom in neutralizing the activity of a variety of Latrodectus venoms [32], 
together with the efficacy of the monoclonal antibody 4C4.1 [31] and Fab antibody fragment FM1 
[57] (also see [58]) in neutralizing the activity of whole L. tredecimguttatus venom or α-LTX-Lt1a, 
there has been some interest in the development of monoclonal antibody therapy for the treatment 
of widow spider antivenom. The advantages of this approach include the virus- and sterile-free 
methods of production and the high purity of recombinant proteins lacking contaminant animal 
proteins derived from animal sera. Also, when compared to the large molecular mass IgG-based 
polyvalent antivenoms, Fab fragment antibodies are likely to diffuse more rapidly due to their 
smaller molecular mass, and distribute more extensively due to a larger apparent volume of body 
distribution. These may result in more rapid inactivation of circulating toxin and an earlier recovery 
from persistent symptoms of latrodectism.  
However, as evidenced by neutralization studies in the CBCNM preparation, the monoclonal 
antibody 4C4.1 is unlikely to have any utility as an antidote in the treatment of latrodectism from 
any species other than L. tredecimguttatus. Monoclonal antibodies may not bind or neutralize α-
LTXs from other species, reflective of the highly homologous but not identical primary structure of 
α-LTXs across the family Theridiidae. Furthermore, in view of the mechanism of action of the 
4C4.1 antibody, it is unlikely that it would be an effective treatment for established envenomation. 
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Pescatori et al. have shown that while 4C4.1 exerts its effect through prevention of tetramerization 
of α-LTX-Lt1a prior to its insertion into cell membranes, once α-LTX-Lt1a tetramer ion channels 
have been formed the antibody is incapable of reversing α-LTX-Lt1a pore formation [30]. Hence, 
polyclonal anti-α-LTX antibodies targeting multiple epitopes on the toxin are likely to be more 
effective at preventing and reversing the toxicity of widow-spider venoms. Furthermore, in view of 
the greater expense in production of specific antitoxins, production of polyclonal antivenoms reared 
in animals exposed to crude venoms remains the least expensive option for the production of 
clinically useful antivenoms. 
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 Table 1: Sequence similarities for latrotoxins from L. hasselti, L. hesperus, and L. mactans 
determined by MS-MS  
Known sequence 
(L. tredecimguttatus) 
 MS-MS Sequence comparison 
 % Identity (identities/total) 
% Similarity 
(similarities/total) 
 L. hasselti 100 (54/54) 100 (54/54) 
α-latrotoxin1 L. hesperus 100 (22/22) 100 (22/22) 
 L. mactans 94.6 (148/150) 98 (147/150) 
α-latroinsectotoxin2 L. hasselti 100 (151/151) 100 (151/151) 
δ-latroinsectotoxin3 
L. hasselti 88.7 (63/71) 91.5 (65/71) 
L. hesperus 91.2 (133/148) 93.2 (135/148) 
 
Similarities and identities are based on comparisons with the known sequences of 
L. tredecimguttatus latrotoxins. 1 Kiyatkin et al., 1990, 2 Kiyatkin et al., 1993, 3 Dulubova et al., 1996. 
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Figure legends 
Fig. 1. Lack of cross-reactivity of the monoclonal antibody 4C4.1 as judged by it ability to prevent 
the neurotoxicity of Latrodectus spp. venoms in the isolated CBCNM preparation. (A) Typical 
effects of 11 µg/ml L. tredecimguttatus venom (a), 10 µg/ml L. mactans (b), 11 µg/ml L. hesperus 
(c), and 11 µg/ml L. hasselti (d) venom on indirectly-stimulated twitch contractions in the CBCNM 
preparation. (B) Typical effects of the same venoms recorded after a 5 min pre-incubation of 
venom with 1 ml (5 µg) of the monoclonal antibody 4C4.1.  
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Fig. 2. SDS-PAGE gel and Western blots of α-LTX-Lt1a and theridiid spider venoms. (A) SDS-
PAGE gel run under reducing conditions showing α-LTX-Lt1a and protein components of 
Latrodectus spp. venoms. Note a consistent protein band in the venom lanes at ~130 kDa, 
consistent with α-LTX-Lt1a. (B-C) Western blot analyses of α-LTX-Lt1a and theridiid venoms 
employing polyvalent anti-α-LTX antibody (B) and the monoclonal antibody 4C4.1 (C) as the 
primary antibodies. Note that purified α-LTX-Lt1a as well as the 130 kDa protein band in 




Fig. 3. Chromatographic fractionation of theridiid spider venoms. (A-F) Size-exclusion FPLC 
chromatograms of Latrodectus and S. grossa venoms. The black shaded portion of the 
chromatogram indicates fractions with vertebrate activity in the CBCNM preparation. (G) 
Chromatogram obtained for the molecular mass marker β-galactosidase (118 kDa) under the same 
elution conditions (H) SDS-PAGE gels run under reducing conditions of L. tredecimguttatus and 




Fig. 4. Anion-exchange FPLC separation of vertebrate-toxic intermediate-mass protein fractions 
from theridiid spider venoms. (A-F) Anion-exchange FPLC chromatograms recorded at 215 nm 
(left-hand ordinate axis) using a linear NaCl gradient (right-hand ordinate axis). The final eluting 
peaks shaded in black (ƒ6 or ƒ7) indicate fractions with vertebrate toxicity. The preceding peaks 
shaded in white (ƒ5 or ƒ6) indicate fractions with insect toxicity. Note the similarity in 
chromatographic profiles and the overlap of adjacent peaks. The anion-exchange profile obtained 
for S. grossa venom is markedly different to that obtained for the Latrodectus venoms. Additionally, 
S. grossa fractions did not exhibit any activity in the chick bioassay. (G-J) Effect of 10 µg/ml ƒ6 or 




Fig. 5. Electrophoretic and reverse-phase separation of vertebrate-toxic anion-exchange FPLC 
fractions. (A-C) Typical SDS-PAGE gels run under reducing conditions of anion-exchange FPLC 
fractions. Lanes correspond to the peaks marked in Fig. 4. (D-F) Analytical C18 RP-HPLC 
chromatograms obtained for vertebrate-toxic anion-exchange FPLC fractions (ƒ6 or ƒ7) recorded 
at 215 nm (left-hand y-axes) using a linear 0.1% TFA/acetonitrile gradient (right-hand ordinate 
axes). Peaks highlighted in black were submitted for MS-MS analysis. 
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Fig. 6. Comparison of the MS-MS peptide sequences from RP-HPLC separation of the vertebrate-
toxic anion-exchange fraction from Latrodectus spp. venoms. The amino acid sequences were 
determined by MS-MS sequencing following overnight (16 h) digestion with trypsin. Sequences are 
aligned against the known sequences of α-LTX-Lt1a, α-LIT-Lt1a and δ-LIT-Lt1a from 
L. tredecimguttatus (light gray) [8-10]. Identities are boxed in dark gray, conservative substitutions 
are in gray italic text. Isoleucine and leucine residues were assigned from the known sequences.  
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Fig. 7. Alignment of the nucleotide sequence of α-LTX-Lh1a with the known sequence of α-LTX-
Lt1a from L. tredecimguttatus. The α-LTX-Lh1a sequence was determined from a gDNA library 
created from female L. hasselti venom glands. Identities are boxed in light gray. The two upward 
arrowheads indicate the N-terminus (AAG) and C-terminus (GAG) of the mature toxin based on 
sequence homology with α-LTX-Lt1a. Labels above and below the sequences indicate the forward 
(‘F’, black) and reverse (‘R’, gray) primers used for PCR. The W at 3585 and 3624 indicates a 




Fig. 8. Comparison of the deduced amino acid sequences of α-LTX-Lh1a with α-LTX-Lt1a. 
Identities are boxed in gray, conservative substitutions are in gray italic text. Proteins are 
numbered from the N-terminus of the mature α-LTX-Lh1a based on homology with α-LTX-Lt1a. 
Note insertion of a glutamate (E) residue at position 4 in α-LTX-Lh1a. The location of the 
conserved furin-like endopeptidase cleavage sites for the signal sequence (–20 to 0) and 
C-terminal propeptide (1281–1382) [11] are highlighted and delineate the mature toxin. The three 
residues marked with arrowheads denote residues in α-LTX-Lh1a that are identical to a variant of 
α-LTX-Lt1a (AAC78471 in EMBL-Bank CDS). Sequences marked ‘MS-MS’ denote residues also 
sequenced by MS-MS analysis. Positions of the 22 ankyrin-like imperfect repeats (R1-R22), 
hydrophobic segments (HS1 and HS2, [10]) and monoclonal antibody 4C4.1 binding epitope 
(residues 1007–1113; [30]) are marked above the sequences. Residue marked ‘X’ in the 
C-terminal propeptide region indicate unknown residues due to uncertainties (A or T) in the one of 
the bases in the corresponding nucleotide triplet: position 1208 is N (corresponding residue in α-




SUPPLEMENTARY FIGURE LEGENDS 
 
Fig. 1S. Sequence comparisons of (A) α-LTX-associated low molecular weight proteins, and (B) 
the binding epitope on α-LTX for monoclonal antibody 4C4.1. Identities are boxed in gray, 
conservative substitutions are in gray italic text. (A) Alignment of the N-terminal partial sequences 
of two novel LMWPs from the anion-exchange FPLC ƒ6 of L. lugubris and L. tredecimguttatus 
venom with known LMWPs. The two novel sequences were determined by Edman degradation. 
Note that LMWP from L. lugubris is 100% identical to the known sequence of LMWP from L. 
tredecimguttatus. (B) Alignment of the binding epitope for monoclonal antibody 4C4.1 on α-LTX 
from L. tredecimguttatus with the corresponding sites in L. hasselti and L. mactans. The binding 
epitope for L. mactans was determined from MS-MS sequencing. 
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Fig. 2S. Identification of ankyrin-like repeats in α-LTX-Lh1a. (A) Consensus sequence for the 33-
residue ankyrin repeat determined from a large number of proteins with ankyrin repeats. Each 
position is color-coded according to the level of conservation described previously [52, 53]. Blue 
indicates a residue that is normally present >50% of the time in ankyrin repeats in a wide variety of 
proteins. Positions are coloured red if residues occur with a higher frequency than any other 
residues and residues had the same physicochemical property (e.g., hydrophobic). Positions were 
colour-coded green if residues occurred with a higher frequency than any other residues but the 
group had different physicochemical properties. Positions that are poorly conserved in the 
consensus sequence were colour-coded yellow and assigned to the amino acid detailed in [53]. (B) 
Identification of the 22 ankyrin-like repeats (R1–R22) in α-LTX-Lh1a. Note the imperfect repeats 
R1, R16 and R17. The percentage similarity with the consensus sequence is indicated at the right 
of the sequences. 
 
